EU Health Data Space to support patients and research

EP and Council negotiators agreed on the creation of a European Health Data Space to ease access to personal health data and to boost secure sharing for the public interest.

  • Citizens will be able to access prescriptions, imagery and lab tests electronically, also from different EU countries
  • Aggregated health data can be shared for research purposes e.g. into cancer and rare diseases
  • Strong privacy safeguards on the manner and the purpose of the sharing of sensitive data

The provisional political agreement on a European Health Data Space (EHDS), reached early on Friday by Parliament and the Belgian Presidency of the Council, outlines that patients will be able to access their personal health data electronically across the EU’s different healthcare systems. The bill also gives health professionals access to their patients’ data, based strictly on what is necessary for a given treatment, and patients will also be able to download their health record free of charge.

Electronic health records (EHR) would include patient summaries, electronic prescriptions, medical imagery and laboratory results (so-called primary use).

Each country would establish national health data access services based on the MyHealth@EU platform. The law would also create a European electronic health record exchange format, and outline rules on data quality, security and the interoperability of EHR systems that will be monitored by national market surveillance authorities.

Data-sharing for the common good with safeguards

The EHDS would allow anonymised or pseudonymised health data, including health records, clinical trials, pathogens, health claims and reimbursements, genetic data, public health registry information, wellness data and information on healthcare resources, expenditure and financing, to be shared for public interest purposes (so-called secondary use). These reasons would include research, innovation, policy-making, education and patient safety purposes.

The sharing of data for advertising or assessing insurance requests will be prohibited. During negotiations, MEPs ensured that secondary use would not be allowed concerning decisions on labour markets (including job offers), lending conditions and other types of discrimination or profiling.
Stronger safeguards for sensitive data

The law ensures patients will have a say in how their data is used and accessed. They must be informed each time their data is accessed, and they will have the right to request or correct incorrect data. Patients will also be able to object to healthcare professionals accessing their data for primary use, except where this is necessary for protecting the vital interests of the data subject or another person. MEPs secured the right for patients to opt out of secondary use, with certain exceptions for public-interest, policy-making or statistics purposes, and protections for intellectual property rights and trade secrets when relevant data is shared for secondary use.

National data protection authorities will monitor the enforcement of health data access rights and will be empowered to issue fines in the event of shortcomings.

Next steps:
The provisional agreement still needs to be formally adopted by both institutions before it can enter into law.

Source: European Parliament | Press Releases (